Preserved Ophthalmic Anti-Allergy Medication in Cumulatively Increasing Risk Factors of Corneal Ectasia
The prevalence of allergies is rising every year. For those who suffer from it, ocular inflammation and irritation can be inconvenient and unpleasant. Anti-allergy eyedrops are a readily available treatment for symptoms of ocular allergy (OA) and can help allergy sufferers regain normal function. Ho...
Main Authors: | Tom Paterson, Serap Azizoglu, Moneisha Gokhale, Madeline Chambers, Cenk Suphioglu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/7/1036 |
Similar Items
-
To See or Not to See: A Systematic Review of the Importance of Human Ocular Surface Cytokine Biosignatures in Ocular Allergy
by: Esrin Aydin, et al.
Published: (2019-06-01) -
A Review of Emerging Tear Proteomics Research on the Ocular Surface in Ocular Allergy
by: Esrin Aydin, et al.
Published: (2022-02-01) -
Femtosecond laser-assisted peripheral additive stromal keratoplasty for treatment of primary corneal ectasia: Preliminary outcomes
by: Mohammadreza Jafarinasab, et al.
Published: (2021-01-01) -
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study
by: Kuna P, et al.
Published: (2023-03-01) -
Prognostic Nomograms Predicting Risk of Keratoconus in Very Asymmetric Ectasia: Combined Corneal Tomographic and Biomechanical Assessments
by: Xiaoyu Zhang, et al.
Published: (2022-02-01)